Vulvar melanoma: is there a role for sentinel lymph node biopsy?

Cancer
J de HulluAte G J Van Der Zee

Abstract

The objective of this study was to evaluate the author's recent, preliminary experience with the sentinel lymph node procedure in patients with vulvar melanoma and to compare this experience with treatment and follow-up of patients with vulvar melanomas who were treated previously at their institution. From 1997, sentinel lymph node procedure with the combined technique (99mTechnetium-labeled nanocolloid and Patente Blue-V) was performed as a standard staging procedure for patients with vulvar melanoma with a thickness > 1 mm and no clinically suspicious inguinofemoral lymph nodes. For the current study, clinicopathologic data from all 33 patients with vulvar melanoma who were treated between 1978 and 2000 at the University Hospital Groningen were reviewed and analyzed. From January 1997 until December 2000, identification of sentinel lymph nodes was successful in all nine patients who were referred for treatment of vulvar melanoma. Three patients underwent subsequent complete inguinofemoral lymphadenectomy because of metastatic sentinel lymph nodes. In follow-up, groin recurrences (in-transit metastases) occurred in two of nine patients, both 12 months after primary treatment. Both patients had melanomas with a thickness > 4 m...Continue Reading

References

Apr 1, 1992·Archives of Surgery·D L MortonA J Cochran
Jun 1, 1982·American Journal of Obstetrics and Gynecology·K C PodratzW F Taylor
Nov 1, 1995·Gynecologic Oncology·C LevenbackD M Gershenson
Oct 1, 1995·Obstetrical & Gynecological Survey·C J DuntonC Hanau
Dec 1, 1996·Cancer·G RäberH P Schneider
Aug 1, 1997·Archives of Dermatology·M S Brady, D G Coit
Mar 4, 1998·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·B B KroonF J Lejeune
Jun 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J E GershenwaldM I Ross
May 26, 1999·Annals of Surgical Oncology·P J BorgsteinP J van Diest
Jan 26, 2000·British Journal of Cancer·C De CiccoG Paganelli
Jun 30, 2000·BMJ : British Medical Journal·P Thomas
Jun 30, 2000·BMJ : British Medical Journal·J M Thomas, E J Patocskai
Aug 2, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A de HulluA G van Der Zee

❮ Previous
Next ❯

Citations

Sep 29, 2006·European Journal of Nuclear Medicine and Molecular Imaging·Sergi Vidal-SicartFrancesca Pons
Jan 29, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Giuseppe TrifiròMario G Sideri
Oct 14, 2005·Current Oncology Reports·Michael FrumovitzCharles Levenback
May 12, 2005·Gynecologic Oncology·Fady Khoury-ColladoOvadia Abulafia
Sep 11, 2003·Best Practice & Research. Clinical Obstetrics & Gynaecology·J A de Hullu, A G J van der Zee
May 7, 2004·Current Opinion in Obstetrics & Gynecology·Aureli Torné, Luis M Puig-Tintoré
May 7, 2004·Current Opinion in Obstetrics & Gynecology·Joanne A de HulluAte G J van der Zee
Jul 10, 2010·Current Opinion in Oncology·Maaike H M OonkAte G J van der Zee
Jun 15, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Ismail MertRouba Ali-Fehmi
Mar 9, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·K K DharR P Woolas
May 22, 2008·World Journal of Surgical Oncology·Ali AyhanPolat Dursun
Jan 29, 2009·World Journal of Surgical Oncology·Stephen P PovoskiEdward W Martin
Jun 5, 2012·Current Oncology Reports·Michael A PostowRichard D Carvajal
Dec 18, 2009·Expert Review of Anticancer Therapy·Maaike H M OonkJoanne A de Hullu
May 17, 2011·Gynecologic Oncology·K M MoxleyK N Moore
Jul 13, 2007·Cancer·Jan HauspyAllan Covens
Sep 2, 2006·Critical Reviews in Oncology/hematology·Angiolo GadducciAndrea Riccardo Genazzani
Jun 13, 2006·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·T Adib, D P J Barton
Jan 15, 2005·Otolaryngologic Clinics of North America·Ivan H El-SayedFrank Civantos
Dec 24, 2004·Surgical Oncology·A-T VlastosG Vlastos
Jun 1, 2010·São Paulo Medical Journal = Revista Paulista De Medicina·Glauco BaiocchiLeonardo Jacomo Valadares
Nov 22, 2017·International Journal of Clinical Oncology·Toshiaki SaitoHidetaka Katabuchi
Jun 28, 2014·The Cochrane Database of Systematic Reviews·Theresa A LawrieAngela Ralte
Oct 12, 2018·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Linda J Rogers, Mauricio A Cuello
Feb 19, 2014·International Journal of Molecular Medicine·Viola A Heinzelmann-SchwarzJames P Scurry
Aug 4, 2020·Minerva ginecologica·Salvatore LopezFrancesco Raspagliesi
Sep 19, 2020·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Basia M MichalskiM Laurin Council
May 24, 2021·Surgical Pathology Clinics·Robert V RawsonRichard A Scolyer
Nov 11, 2021·American Journal of Obstetrics and Gynecology·Liat BainvollKoji Matsuo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the American Academy of Dermatology
Mary Ellen WechterTimothy M Johnson
European Journal of Nuclear Medicine and Molecular Imaging
Katalin ZámbóJózsef Bódis
Current Treatment Options in Oncology
Amy A Hakim, Keith Y Terada
© 2022 Meta ULC. All rights reserved